U.S. markets closed

Paratek Pharmaceuticals, Inc. (PRTK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.01-0.11 (-1.35%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/15/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
393.90M291.19M246.91M236.51M133.48M
Enterprise Value 3
520.75M393.69M323.04M304.60M180.92M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
7.916.466.808.026.24
Price/Book (mrq)
N/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
11.1024.5723.6532.6622.84
Enterprise Value/EBITDA 7
-6.88-20.08-20.84-17.02-7.96

Trading Information

Stock Price History

Beta (5Y Monthly) 1.56
52-Week Change 378.79%
S&P500 52-Week Change 348.25%
52 Week High 38.75
52 Week Low 33.81
50-Day Moving Average 37.51
200-Day Moving Average 36.61

Share Statistics

Avg Vol (3 month) 3489.16k
Avg Vol (10 day) 31.13M
Shares Outstanding 546.89M
Implied Shares Outstanding 6N/A
Float 40.28M
% Held by Insiders 110.98%
% Held by Institutions 154.35%
Shares Short (Mar 30, 2021) 44.26M
Short Ratio (Mar 30, 2021) 412.62
Short % of Float (Mar 30, 2021) 49.49%
Short % of Shares Outstanding (Mar 30, 2021) 49.08%
Shares Short (prior month Feb 25, 2021) 44.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 28, 2014
Ex-Dividend Date 4Oct 30, 2014
Last Split Factor 21:12
Last Split Date 3Oct 30, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin -205.74%
Operating Margin (ttm)-160.91%

Management Effectiveness

Return on Assets (ttm)-22.06%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)46.92M
Revenue Per Share (ttm)1.06
Quarterly Revenue Growth (yoy)78.70%
Gross Profit (ttm)14.35M
EBITDA -74.93M
Net Income Avi to Common (ttm)-96.54M
Diluted EPS (ttm)-2.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)125.16M
Total Cash Per Share (mrq)2.67
Total Debt (mrq)252.84M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.85
Book Value Per Share (mrq)-2.20

Cash Flow Statement

Operating Cash Flow (ttm)-103.42M
Levered Free Cash Flow (ttm)-61.44M